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ABSTRACT 
Brian F. Bragassa: Accelerated Invisalign® in conjunction with AcceleDent Aura®: A  
Randomized Clinical  
(Under the direction of Ching-Chang Ko) 
 
Introduction: The objective of our study was to determine if vibration therapy increases 
the efficiency and accuracy of incisor alignment, accuracy of overbite correction as well as 
decreases discomfort associated with accelerated (4-day) Invisalign®. Methods: 33 patients were 
enrolled in a double-blinded parallel, randomized prospective clinical trial at the UNC 
Department of Orthodontics. Participants were randomly allocated into one of 3 groups: 2-week 
aligner wear (G1, n=10), 4-day aligner wear without vibration (G2, n=12) and 4-day aligner wear 
with vibration (G3, n=11). 3-D virtual models of maxillary and mandibular dentition were 
captured at 2 different time points: Baseline (To) and following 12-weeks of treatment (Tfinal). 
Efficiency and accuracy of incisor alignment for 63 pre/ post-treatment dental arches was 
determined by using the percent reduction and percent accuracy of reduction in Proximal Contact 
Point Discrepancy Index (PCPDI). The accuracy of OB correction was determined for 29 pot-
treatment models by measuring the percent accuracy of overbite correction (OB). Finally, 
discomfort and the need for analgesic medication was investigated for each subject at 4 time 
points (T4-days, T2-weeks, T6-weeks, Tfinal) using a Visual Analog Scale (VAS) and a survey, 
respectively. Results: There was a significant increase in the efficiency of incisor alignment 
between groups G1 (18.9%) and G3 (29.12%) (P= 0.003). However, there was also a significant 
decrease in the percent accuracy of incisor alignment between group G1 (48%) and G2 
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(36%)/G3 subjects (37%)(P= 0.023, .047). There was no significant difference in the percent 
accuracy of overall OB correction between the 3 groups (P= 0.331, .0664). However, the percent 
accuracy of simple OB correction was statistically greater than complex OB correction in within 
each group (P= 0.039,  <0.001, .047). Pain scores tended to be higher for G2 subjects but the 
difference was only significant at one time point (T2-weeks) (P= 0.03). Vibration therapy did not 
significantly increase the efficiency/accuracy of incisor alignment (P= 0.089, 0.774) or the 
accuracy of OB correction (P= 0.33, 0.064) and decrease the pain associated with accelerated (4-
day) Invisalign®(P= 0.59, 0.85). Conclusion: Accelerated (4-day) Invisalign® increases the 
efficiency but decreased the accuracy of incisor alignment when compared to a 2-week control 
group. Simple OB correction is significantly more accurate than complex OB correction when 
using Invisalign therapy. Vibration therapy has no effect on the efficiency and accuracy of 
incisor alignment, accuracy of OB correction nor the discomfort associated with accelerated (4-
day) Invisalign®. 
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THE EFFECT OF ACCELEDENT AURA® ON THE EFFICIENCY AND ACCURACY 
OF INCISOR ALIGNMENT AS WELL AS DISCOMFORT USING ACCELERATED (4-
DAY) INVISALIGN®: A RANDOMIZED CLINICAL TRIAL 
 
Introduction 
 
Clear aligners and other advances in orthodontic technology such as ceramic and lingual 
braces have met the esthetic demands of most orthodontic patients, yet duration of treatment 
continues to be one of the most challenging aspects of the orthodontic practice.1 The benefits of 
accelerated orthodontic treatment are mutually beneficial to both the patient and the orthodontic 
provider.  Reduced treatment time decreases the risk of undesired treatment sequelae (e.g., 
demineralization, caries and root resorption) for patients. Moreover, orthodontic providers report 
increased profit margins due to reduced chair time, increased patient satisfaction, and increased 
organic growth due to differentiation of the practice.1 Therefore, it is unsurprising treatment 
efficiency continues to be the focus of orthodontic research as well as development in 
orthodontic industry.  
Historically, orthodontic treatment time (OTT) involves 2 or more years in fixed 
appliances. However, there is an ever-increasing demand by the public for shorter treatment 
times.1 Most parents find 12 to 18 months as an acceptable length of treatment but adolescent 
patients would prefer less than 6 months.2 OTT is determined by severity of the initial 
malocclusion, age of the patient and the rate of orthodontic tooth movement (OTM), which is 
determined by the complex cellular process of alveolar bone remodeling.3 Significant 
advancements in the understanding of bone biology and the mechanism of alveolar bone 
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remodeling have led to the development of multiple techniques intended to reduce OTT by 
accelerating the biologic response required for OTM.4 According to Uribe, surgical and 
mechanical/physical techniques can be used to accelerate OTM.1 Surgical techniques are 
invasive procedures such as periodontally accelerated osteogenic orthodontics and corticision, 
which utilize regional acceleratory phenomenon (RAP), or microfractures in the alveolar bone to 
stimulate osteocyte differentiation and maturation, to increase the rate of OTM.5 However, only 
11% to 34% of patients are willing to undergo invasive procedures in conjunction with their 
orthodontic care.1 Mechanical/physical techniques include: low-level laser therapy, low-level 
light therapy, and micro-vibration therapy, which the patients use in conjunction with traditional 
orthodontic care at an additional treatment fee. 6, 7 The basis for the effects of vibration on 
accelerating OTM is the stimulation of differentiation and maturation of cells required for 
alveolar remodeling.3 Therefore, the mechanism for action of vibration therapy appears to be 
very similar to the effects of more invasive techniques such as corticotomy, or bone perforation.3 
Early animal studies and clinical case reports investigating the effects of vibration on 
OTM yielded promising results.8–10 Vibration force applied to Macaca fuscata monkeys for 1.5 
hours per day over 3 weeks increased tooth movement by 30 percent.9 Using a split-mouth 
design, Leethanakul demonstrated vibrations generated from the head of an electric toothbrush 
locally increased proinflammatory mediators such as Interleukin (IL)-1ß, which have been linked 
to increased osteoclastic activity, inflammation, and tooth movement.11 A retrospective clinical 
study evaluating the rate of alignment and leveling in the mandibular arch of non-extraction 
subjects reported a 30% increase in the rate of OTM using vibration therapy.12 According to 
Nishimura et al., the accelerated OTM resulted from increased RANKL expression in the 
periodontal ligament. Based on this preliminary data, many orthodontic providers supplemented 
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traditional orthodontic treatment with vibration therapy as a means to reduce OTT. Also based 
on the premise that vibration can reduce OTT, 50% to 61% of patients are willing to pay for and 
undergo treatment with a vibration appliance.1 
In 2009, OrthoAccel Technologies (Houston, TX) introduced AcceleDent®, a class II 
medical device scientifically proven to accelerate OTM and reduce OTT.  However, a critical 
review of the literature supporting AcceleDent indicates those studies have low-quality evidence 
due to poor study design and small sample sizes. Recently conducted prospective clinical trials 
with favorable study designs and high-quality evidence reported vibration therapy has little effect 
on the rate of OTM. For example, no difference was noted in the rate of initial alignment in the 
mandibular arch of non-extraction subjects in a clinical trial using the Tooth Masseuse appliance 
(111 Hz; 0.06 N or about 6g).4 Moreover, there was no evidence Acceledent® increased the rate 
of OTM, or final alignment with fixed appliances in the mandibular arch of patients having 
mandibular premolars extractions.13  
Despite a lack of scientific evidence, the Acceledent Aura® device continues to be 
marketed aggressively by the manufacturer as well as by some orthodontic providers as a means 
to facilitate accelerated reactivation schedules for clear aligner patients. According to OrthoAccel 
Technology, Inc. and their supporters, if the AcceleDent Aura® device is used in conjunction 
with clear aligner therapy, OTT can reduce by as much as 50%. This is achieved by increasing 
the efficacy of aligner treatment and significantly reducing the need for refinement treatment.14 
Orthodontic providers who recommend accelerated aligner schedules in conjunction with 
vibration therapy report accelerated tooth movement, but further studies are required to 
determine if vibration therapy is responsible for the reduced OTT. This is especially true with the 
recent announcement by Align Technologies, Inc. to recommend 7-day aligner wear for all 
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Invisalign patients without the use of adjunctive therapies. Key opinion leaders, who serve on the 
North American Clinical Advisory Board for Align Technology, claim significant advancements 
in Invisalign product innovation including “G-Series” feature, SmartTrack® aligner material and 
clinically proven predictability have allowed the company to confidently recommend one-week 
wear.15  
Manufacturers of vibration devices also claim daily micro-vibrations can reduce the 
discomfort associated with orthodontic treatment, but clinical evidence is lacking. One clinical 
trial conducted by Lobre et al16 showed micro-pulse vibration significantly reduce the pain 
scores for overall pain and biting pain during a 4-month evaluation period. Moreover, the same 
study indicated vibration therapy might be a more effective and safer method of analgesia than 
using medication. Conversely, however, multiple other high-quality clinical trials have reported 
little effect of vibration on orthodontic pain and, or quality of life. For example, Woodhouse et 
al17 indicated there was no difference in the discomfort experienced, or the consumption of 
analgesics in patients with fixed appliances. Katchooi et al.18 determined there was a trend for 
subjects using vibration in conjunction with 7-day clear aligner therapy (CAT) to report less 
pain, but the difference was only significant for 1 out 14 time points. In addition to the effect of 
vibration on treatment pain, the Katchooi et al18 study also investigated the effect of vibration 
therapy on the efficacy of treatment associated with accelerated (7-day) CAT. They found 81% 
of the subjects were able to successfully complete their series of aligners, therefore, it is 
appropriate to further investigate the effect of vibration on the efficacy of OTM and discomfort 
associated with accelerated (4-day) CAT. More clinical studies are needed to fully understand 
the effect of accelerated aligner reactivation schedules (ARS) on the efficiency, efficacy and 
discomfort associated with CAT.  
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Therefore, we conducted a prospective randomized clinical trial (RCT) designed to 
determine the effect of vibration therapy and ARS on the efficiency, efficacy and discomfort 
associated with accelerated (4-day) CAT. Hopefully, the results of our RCT will provide 
orthodontic providers with high-quality evidence necessary to make ethical and evidence-based 
recommendations to patients regarding the effect of vibration as well as ARS on the quality as 
well as OTT of CAT. Moreover, patients can make an informed decision on whether the 
potential benefits of vibration and 4-day CAT justify any risks, or additional cost of treatment. 
Specific Objectives and Hypotheses 
The aims of this RCT are to determine the effect of vibration therapy and a 4- day aligner 
schedule (DAS) on: (1) the efficiency of upper and lower incisor alignment, (2) accuracy of 
upper and lower incisor alignment, and (3) the discomfort associated with accelerated (4-day ) 
CAT. 
The null hypotheses tested in this study were the following: (1) vibration therapy does not 
increase the efficiency of upper and lower incisor alignment, (2) vibration therapy will not 
improve the accuracy of upper and lower incisor alignment, and (3) vibration therapy does not 
decrease the discomfort associated with accelerated (4-day) CAT. 
Material and Methods: 
Trial design and any changes after trial commencement 
 This study was designed as a double blinded, single-centered 3-arm, parallel, prospective 
randomized clinical trial with 1:1:1 allocation ratio.  
Participants, eligibility criteria and settings 
 Ethical approval was granted by the Office of Human Research Ethics at the University 
of North Carolina (reference number: 16-0167). The clinical trial was registered at the US 
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National Institutes of Health (ClinicalTrials.gov) #NC NCT02868554. See CONSORT flow 
diagram (Figure 2). 
 The study population was drawn from patients pursuing Invisalign® treatment in the 
postgraduate orthodontic clinic of the University of North Carolina (UNC). Patients were 
included for participation based on the following criteria: (1) being within the ages of 18-65 
years old, (2) good health determined by a current medical history, (3) full adult dentition 
including second molars in both dental arches, (4) normal pulp vitality and healthy periodontal 
tissues as determined by intraoral exam, (5) initial malocclusion with mild to moderate dental 
crowding or spacing (≤ 6mm), (6) non-extraction Invisalign treatment with ClinCheck treatment 
plans prescribing more than 21 active aligners with simultaneous tooth movement of anterior 
teeth and no deviation from default amounts of tooth movements prescribed in each aligner 
stage, (7) no mid-course correction, or additional aligners, and (8) willingness to and ability to 
comply with study procedures, attend study visits, and complete the study protocol. 
 Patients were excluded from participation based on the following criteria: (1) individuals 
diagnosed with systemic diseases such as diabetes, hypertension, temporomandibular disorders, 
or cranio-facial syndromes, (2) chronic use of any non-steroidal anti-inflammatory medications, 
estrogen, calcitonin, or corticosteroids, (3) history of use or current use of bisphosphonate 
medication or other medication fro treatment of osteoporosis, (4) current smoker (not within the 
last 6 months), (5) significant periodontal disease (>4mm pocket depth or >2mm recession), (5) 
active caries, or new dental restorations during treatment (6) initial malocclusions with severe 
crowding or spacing (>6mm), (7) impacted teeth and, or closure of extraction spaces, requiring 
fixed appliances or adjunctive procedures other than clear aligners, (8) ClinCheck treatment 
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plans with less than 21 aligners, or plans that failed to start all tooth movement simultaneously, 
and finally, (9) failing to comply with research protocols.  
 Enrolled subjects were allocated into one of 3 groups: 14-DAS (control- G1), 4-DAS 
(G2), and 4-DAS plus vibration therapy using Acceledent Aura® (G3). Informed consent and 
assent were obtained prior to initiating the clinical trial protocol. In total 67 patients were 
screened for eligibility, 34 patients were excluded for not meeting the previously mentioned 
criteria, and 33 patents were enrolled under the supervision of Dr. Bill Gierie, who is an Elite top 
1% Invisalign provider and also serves as a KOL for Invisalign. Dr. Gierie was blinded to group 
allocation of all subjects during the initial set-up and approval of the ClinCheck treatment plan, 
however, he was made aware if the patient was in the study to ensure no additional modifications 
were requested to alter the rate of programmed tooth movement per aligner (0.25mm/aligner). 
Once the aligners arrived from the manufacture, enrolled patients were scheduled for aligner 
delivery and randomly allocated to one of the 3 groups using third party randomization software.  
According to group allocation and Invisalign® start date (To), customized aligner 
schedules were issued to all subjects and recall appointments were scheduled for data 
acquisition. Subjects in the control group (G1) were instructed to wear each aligner set 14 days. 
Subjects receiving an accelerated aligner schedule (G2/G3) were instructed to wear each aligner 
set 4 days. All subjects were instructed to wear each aligner at least 22 hours per day and 
progress to the subsequent aligner based upon their customized schedule. Subjects receiving 
vibration therapy (G3) were issued a fully charged Acceledent Aura® device with operating 
instructions and compliance counseling. Vibration therapy was applied for 20 minutes per day at 
a force of .25N (25g) at a frequency of 30Hz. G3 subjects were blinded from the fact that the 
Acceledent Aura device contains Fastrac® software which is a microprocessor that stores the date 
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and duration of use each time the device was activated. All subjects were recalled at the 
following time points for data collection:  T4-days, T2-weeks, T6-weeks, and T12-weeks after the 
Invisalign start date.  
The investigator completed the following research steps at each recall visit: (1) obtain 
virtual models of maxillary and mandibular dental arches using Trios 3Shape scanner and (2) 
determine discomfort experienced by the subject at the onset of subsequent aligner delivery 
using the Faces Pain Scale®. Subjects were also asked to indicate the number of hours they 
typically wear the Invisalign trays and if analgesics were used to relieve discomfort associated 
with their treatment. 
Under faculty supervision, orthodontic residents completed the following clinical steps 
specific to each recall visit: (To)[a] deliver aligner #1, (T4-days) [a] deliver aligner #s: 2-4 to 
G2/G3 subjects only, (T2-weeks) [a] place composite attachments prescribed in the ClinCheck 
treatment plan and [b] deliver aligner #s: 2-3 to G1 subjects and aligner #s: 5-11 to G2/G3 
subjects, (T6-weeks) [a] deliver aligner #s: 4-6 to G1 subjects and aligner #s: 12-21 to G2/G3 
subjects, (T12-weeks) [a] terminate study protocol and continue treatment under the guidance of 
attending faculty, Dr. Bill Gierie. 
Outcomes (primary, secondary and tertiary) and any changes after the trial 
commencement 
 
The primary outcome measure within the three groups was the percent reduction in 
Proximal Contact Point Discrepancy Index (PCPDI), which involves measuring the linear 
displacement of the anatomical contact of each incisor from the adjacent tooth anatomic point, 
the sum of these displacements representing the relative degree of anterior irregularity (Figure 1). 
Perfect alignment from the mesial aspect of the left canine to right canine would theoretically 
have a score of 0.19 For each subject at baseline (T0) and following 12-weeks of treatment (T12-
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weeks), the PCPDI was determined separately for maxillary (#s: 6-11) and mandibular (#s: 22-27) 
anterior teeth on digital study models (.stl) captured with intra-oral scans. The percent reduction 
in PCPDI was determined with the following equation: % reduction PCPDI 100%: [(|initial 
PCPDI-achieved PCPDI|/ initial PCPDI)*100].  
The secondary outcome measure, within each group, was the percent accuracy of PCPDI 
reduction, which was defined by the following equation: % accuracy PCDP reduction [(|initial 
PCPDI – achieved PCPDI|) / (|initial PCPDI – goal PCPDI|)*100]. Again, because in our study 
only reflected outcomes following the initial 12 weeks of treatment, the goal PCPDI for our 
subjects was determined as a percentage of the total predicted PCPDI correction (G1= 6 aligners/ 
total # aligners/ G2&G3= 21 aligners/ total # of aligners). For example, the equation for goal 
PCPDI in control group subjects (G1) was: [(|initial PCPDI - predicted PCPDI |) x |6 aligners/ 
total # of active aligners|]. Calculating the accuracy of the percent reduction in PCPDI was 
necessary to overcome the discrepancy of number of aligners completed within each group 
during the 12 weeks study.  
The tertiary outcome measurement, as determined by the subjects within each group, was 
the mean (%) pain score associated with the onset of each aligner set. Pain scores were collected 
using a numerical analog scale (Pain Faces Scale®, 0 {no pain}- 10 {severe pain}), which 
allowed subjects to rate the discomfort associated with inserting the each subsequent aligner. In 
addition to pain scores, subjects indicated, yes (Y=1), or no (N=0), if analgesics were used to 
relieve discomfort associated with their treatment.  
Finally, daily compliance using the AcceleDent Aura® device as well as the Invisalign 
trays was monitored throughout the study. Compliance with the vibration device was measured 
using the OrthoAccel, Inc. proprietary software, FastTrac®. All subjects were advised to wear the 
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Invisalign trays 20-22 hours per day and compliance pertaining to use of the Invisalign trays was 
self-reported using a questionnaire. Survey data was collected at each recall visit: T0, T4-days, T2-
weeks, T6-weeks, and T12-weeks. 
To obtain the T0, T12-weeks and goal PCPDI measurements, we imported final ClinCheck 
models (.stl) as well as the intra-oral digital study models (.stl) into Geomagic DesignX64 
software. For each digital model at each time point, a single blinded investigator (B.B) 
reproducibly selected the proximal contact points of maxillary and mandibular incisors.  
Sample size calculation 
The main outcome measure in this study was the (1) percent reduction in PCPDI during 
the initial 12-weeks of treatment. Sample size estimation was completed using G*Power 3.1 
software and showed a total of 21 participants (42 dental arches), 7 participants (14 dental 
arches) in each treatment arm, was required to demonstrate a clinically significant difference in 
the primary outcome of a 75% increase in the rate of incisor alignment between G1 and G2/G3, 
with 80% power, a standard deviation of 0.1, and an alpha of 0.05, using two sample T-test, and 
with the null hypothesis of equal effect. In addition, to allow for a potential 30% dropout rate, the 
sample size was increased to 30 subjects. 
Interim analyses and stopping of guidelines 
 No intervention analysis was performed during the study. During the design of study 
protocol, we decided the trial would be stopped if any harm came as a result of the interventions. 
Randomization 
 An independent, third party biostatistician, using an electronic program, R 3.4.2, 
completed randomization of the subject allocation sequence. All subjects enrolled within the 
study were randomized in blocks of 6 to the 3 groups that correspond to one of the 3 treatment 
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options to be studied. Allocation concealment was secured by contacting the sequence generator 
for assignment. 10 subjects were randomized to the 14-DAS (G1), 12 subjects were randomized 
to the 4-DAS (G2), and 11 subjects were randomized to the 4-DAS plus vibration therapy (G3). 
All subjects enrolled within the study (33) received an allocation intervention. 
Blinding 
 Blinding of either the patient, or the assigned orthodontic resident, was not possible 
during this clinical trial due to a lack of sham vibration devices. It was also the opinion of the 
investigator than a shame device was not a realistic way of eliminating the placebo effect, which 
has been repeatedly discussed in previous studies evaluating pain scores. However, the part-time 
faculty member (B.G.) was blinded during the initial set-up of the ClinCheck treatment plans and 
the research investigator (B.B.) was blinded during data analysis. The digital models used to 
perform the PCPDI measurements were de-identified and assigned a three-digit code to ensure 
the investigator was unaware of the patient’s intervention method.  
Statistical Analysis 
 Descriptive statistics on demographic, clinical characteristics, and outcomes Invisalign 
treatment were calculated. Since a large correlation coefficient (0.25) was present between upper 
and lower teeth in the percent reduction of PCPDI, repeated measures ANOVA was used as the 
primary statistical method to account for the dependence. A categorical variable with 3 levels 
was created for the group in the linear mixed effects model with a random intercept. The 
statistical significance of the difference between groups in both primary and secondary outcomes 
was tested using a t-test obtained from the parameter estimation. Since there is no significant 
difference in baseline characteristics, we did not adjust for any covariates in the mixed effects 
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model. P-values less than 0.05 were considered statistically significant. All of the statistical 
analyses were implemented using SAS 9.4 (Cary, NC). 
Compliance data downloaded from the devices were analyzed. The difference the 
primary, secondary and tertiary aims between compliers and non-compliers were measured using 
the Wilcoxon rank sum test. Self-reported aligner compliance data, pain level on the numeric 
scale and the need for analgesic medication data were gathered from the subject surveys and 
analyzed. We will use Wilcoxon rank sum test to measure the differences between the arms of 
the study. 
Results: 
Participant Flow 
Open enrollment began in May 2016 and continued until November 2017. 33 subjects 
(mean age, 32.3yrs; SD: 9.21; max: 57yrs; min: 18yrs) were randomized to one of 3 intervention 
groups: 14-day aligner schedule (G1), 4-day aligner schedule (G2), and 4-day aligner schedule + 
vibration therapy (G3). Data from 2 subjects (2 maxillary arches and 1 mandibular arch) were 
eliminated from the data sample prior to analysis because the ClinCheck® treatment plans did not 
initiate tooth movement simultaneously. This resulted in the final analysis of 63 dental arches 
(31 maxillary and 32 mandibular). The recruitment and follow-up of all subjects during the study 
is shown in the CONSORT flow diagram (Figure 2). No subject was lost to follow-up during this 
study.  
Baseline Data 
Table 1 shows the similarity in the distributions across treatment groups for demographic, 
initial PCPDI for maxillary and mandibular dentition as well as the average number of aligners 
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used per group. Table 2 displays the mean self-reported aligner use per day within each group. 
Figure 3 illustrates the compliance with the AcceleDent Aura® by subjects within G3. 
Numbers analyzed for the primary aim (percent reduction in proximal contact point 
discrepancy index)  
 
Our results indicated a statistically significant difference in the percent reduction of the 
PCPDI between the control group (G1-18.9%) and the accelerated Invisalign in conjunction with 
vibration group (G3-29.1%) (P= 0.003). However, no statistically significant difference was 
found between the control group (G1) and the accelerated Invisalign group (G2- 23.8%) 
(P=0.125) nor the accelerated Invisalign group (G2) and the accelerated Invisalign in conjunction 
with vibration group (G3) (P=0.089) (Figure 4). These results were not altered after adjusting for 
the various confounding factors.  
Compliance was found to drop-off markedly during the period of the trial. Only 6 
participants (54%) met the criterion of being considered compliant by using the vibration device 
75% of the time or more (Figure 3). The mean percent reduction of PCPDI in the compliant 
subjects was 27.9% while non-compliant subjects had a 31.6% reduction, thus, showing 
vibration therapy had little effect on the efficiency of incisor alignment. The mean compliance 
with aligner use was within recommended range (20.9 hours per day) and the means of use 
within the groups was not statistically different (Table 3) 
Numbers analyzed for the secondary aim (% accuracy of incisor alignment) 
There was a statistically significant difference in the mean accuracy of PCPDI reduction 
(%) between the control group (G1- 48.3%) and the accelerated Invisalign group (G2- 
36.1%)(P=0.0235) as well as the accelerated Invisalign in conjunction with vibration group (G3-
37.7%) (P=0.047). However, no statistically significant difference was found when evaluating 
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the effect of vibration between G2 and G3 (P=0.284). These results were not altered after 
adjusting for the various confounding factors. (Figure 5) 
Compliance with the vibration device was found to drop-off markedly during the period 
of the trial. Only 6 participants (54%) met the criterion of being considered as good compliers by 
using the vibration device 75% of the time or more (Figure 3). The mean accuracy of PCPDI 
reduction in compliant subjects was 38.2% while the non-compliant subjects had a 37.3% 
reduction, thus, showing vibration therapy had little effect on the accuracy of incisor alignment. 
The mean compliance with aligner use was within recommended range (20.9 hours per day) and 
the means of use within the groups was not statistically different (Table 3) 
Numbers analyzed for tertiary aim (Pain scores and analgesic consumption) 
 When comparing mean pain scores in each group by time point, the only significant 
difference occurred at T2-weeks, where G2 subjects experienced significantly more discomfort than 
G1 subjects (P= 0.033). (Figure 6) The mean pain scores decreased significantly by time point 
throughout the 12 week study period (P= 0.005).  When investigating the consumption of 
analgesics, there was no statistically significant difference between the groups (P= 0.612). 
Analgesic medication consumption was the highest at T1 for all groups (G1-14%, G2- 17%, G3-
27%). (Figure 7) 
Error of the Method 
To reduce effects of random measurement error and calculate intra-operator reliability, 
the same single operator (B.B) manually repeated the steps to measure the PCPDI measurements 
3 times and allowed 1-weeks time to pass between measurements. The accepted PCPDI value 
used to calculate the percent reduction and accuracy of PCPDI correction was the average of 3 
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completed measurements. The Dahlberg20 measurement error calculations showed a 0.1mm 
difference between the initial and repeated measures. 
Harms 
 There was no evidence of adverse events, or safety hazards, to the soft or hard tissues of 
the participants during the trial.  
Discussion: 
Main findings in the context of the existing evidence, interpretation 
Given the substantial growth of clear aligners within the orthodontic market and the 
increasing demand for reduced treatment time, there is a substantial need to clearly understand 
the factors contributing to OTT when using CAT.  Orthodontic providers need high quality 
evidence to base their treatment recommendations on and to help avoid potential liabilities 
associated with accelerated orthodontic treatment.21 Patients should not be misled by the 
aggressive marketing strategies of orthodontic manufacturers, or orthodontic providers 
attempting to differentiate their practice from competitors with false claims of accelerated 
treatment.  
Despite significant advancements in the understanding of bone biology, OTT continues to 
be limited by the rate of OTM, which is further affected by case complexity and the age of the 
patient. Several invasive and non-invasive techniques have been developed as means of 
accelerating the intricate cellular pathways involved with alveolar bone remodeling.1 Although a 
few published scientific and clinical studies indicate vibration can accelerate OTM, the clinical 
significance of the benefits resulting from vibration therapy remains in question.  
In this RCT, we evaluated the effects of accelerated (4-day) CAT and vibration therapy 
on the efficiency and accuracy of upper and lower incisor alignment. The demographics of our 
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study sample were 64% female, however, this reflects a “real-world” scenario as females are 
generally more concerned with esthetics and duration of treatment.22 The average of age was 
similar between allocation groups (32.3yrs, SD: 9.85). Additionally, there was no difference in 
the characteristics of the initial malocclusions between the groups and the mean number of 
aligners (G1-30.5, G2-32.3 and G3-32.6). Thus, our study sample was ideal for determining the 
aims of our study.  
When evaluating the efficiency of incisor alignment, which again was the percent 
reduction in PCPDI, between the 3 groups, we noted a trend for the accelerated groups (G2/G3) 
to be more efficient than G1, which seems logical because subjects in G2 and G3 completed 21 
aligners versus the 6 aligners completed by G1 subjects. The only significant difference was 
noted between G3 subjects and G1 subjects which means the effect of a 4-day aligner schedule 
plus vibration was more efficient than the 2-week control group. However, because there was not 
a significant difference between G2 and G3 subjects, we can conclude vibration had no effect on 
the efficiency of incisor alignment. These results agree with multiple previously conducted 
prospective RCTs, which indicated the effect of vibration on the rate of OTM is negligible.13,23,18  
To more thoroughly understand the effect of vibration therapy on accuracy of accelerated 
(4-day) CAT, we compared the accuracy of achieved percent reduction in PCDPI to the 
predicted reduction in PCPDI within each group. Our results indicated G1 subjects achieved 25% 
more of the predicted incisor alignment than G2 and G3 subjects. The effect of vibration resulted 
in a slight increase (3%) in the accuracy of the achieved incisor alignment, but the impact was 
not significant. When comparing our study recently published by Katchooi et al24., who reported 
65% accuracy of incisor alignment using 7-DASs ± vibration, our results indicate 4-DASs ± 
vibration exacerbate the accuracy of incisor alignment. 
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Our results indicate mean pain scores were low overall (<2.5/10) and mean pain scores 
significantly decrease over the course of treatment. Our results indicated a trend that G1 and G3 
subjects may have experienced less pain than G2 subjects but the difference was only significant 
at the 2-week follow up appointment. Vibration seemed to reduce some of the pain experienced 
between G2 and G3 subject, although the difference was not significant. This result was very 
similar to the findings published recently by Katchooi et al18, who compared pain levels 
associated of 7-day ARS with a 2-week CAT protocol. Additionally, our findings showed there 
was no difference in consumption of analgesic medication between the groups, but it was 
interesting to note our subjects only used pain medication following delivery of the initial aligner 
and mean pain scores were similar to those reported by Katchooi et al24. Perhaps the most 
interesting finding from out pain data was that G2 subjects consumed less pain medication than 
G3 subjects. This finding may provide some explanation of why G3 subjects experienced less 
pain than G2 subjects. If vibration did, in fact, play a role in reducing discomfort associated with 
treatment, the effect was undoubtedly not clinically significant. 
Similar to previously published studies evaluating the effect of vibration therapy, our 
subjects demonstrated poor compliance using the AcceleDent Aura device. According to the 
AcceleDent Fastrac® usage reports collected in our study, only 6 of the 11 (54%) G3 subjects 
used the device as directed by the manufacturer more than 75% of the days. However, there was 
no significant difference in the accuracy of incisor alignment between compliant and non-
compliant subjects (38% and 37%, respectively). The poor compliance noted in our study is 
reflective of a real-world orthodontic practice; therefore, all AcceleDent users were examined in 
determining the effect of vibration therapy.   
	  18	  
Interpretation of our results indicates accelerated (4-day) Invisalign can increase the 
efficiency of incisor alignment without significantly more discomfort when compared to 2-week 
or 7-day regimens. However, our study also reveals the side effect of increased efficiency is a 
significant reduction is the accuracy of desired incisor alignment. Our study revealed trends 
leading to the possibility of vibration therapy having a positive effect on efficiency and efficacy 
of accelerated CAT, but the difference was not statistically significant within our relatively small 
sample size. The majority of improved efficiency noted in the accelerated groups resulted from 
the 4-DAS. One could argue that with a larger sample size, or improved compliance using the 
vibration device, the difference in the efficiency between groups G2 and G3 may have been 
statistically significant, but the clinical significance would undoubtedly remain trivial. 
In terms of OTT with CAT, we cannot definitively conclude overall treatment time will 
be reduced because of the accuracy of accelerated CAT is significantly reduced. Orthodontic 
providers and patients using accelerated (4-day) aligner schedules may require more mid-course 
corrections, or refinements, to achieve the desired result of treatment. Even if significant 
compensations are made in the ClinCheck treatment plan as a means to overcome the side effects 
of 4-DAS, OTT will not, necessarily, be reduced because more aligners will be required to 
achieve the same desired outcome. Increasing the number of aligners may contribute to patient 
burn out, which often leads to poor compliance and potentially, a negative overall experience 
with treatment.18 
The choice of using accelerated ARSs with, or without, vibration as an adjunctive therapy 
to accelerate OTM and potentially reduce OTT will continue to be at the discretion of the 
orthodontic provider and patient. However, the results of this study provide scientific evidence to 
help providers make more informed treatment recommendation for which they are liable. More 
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long-term clinical studies with larger sample sizes and are needed to fully understand the effect 
of vibration and accelerated ARSs on the efficiency and accuracy of CAT. The ideal time 
regimen for each aligner set likely varies based on the initial malocclusion and treatment 
outcomes desired by the patient.  
Limitations 
 Clinical studies that provide good-quality patient care while testing alternative treatments 
must, by their very nature, involve compromises. One limitation of our study was not blinding 
the research subjects to their intervention group. However, significant patient blinding was 
impossible, while maintaining the clinical applicability of the study. Previous studies have used 
sham vibration devices, but with questionable efficacy in regards to blinding. The absence of 
blinding of our subjects most likely affected the pain scores reported within each group due to 
the presence of, or lack of, placebo effect. The results of our study were also subject to the 
potential for poor patient compliance with the Invisalign, or vibration device. Although patients 
reported acceptable levels of compliance wearing Invisalign trays, we were unable to verify the 
daily frequency of aligner use for each patient. Additionally, we do not know the short versus 
long-term effects of vibration therapy on OTM, but the short (12-week) evaluation period in this 
trial may not have allowed for the cumulative affect of vibration therapy. Finally, the effect of 
bite force on the vibration device mouthpiece may have affected the results of our study. 
Generalizability 
 The demographics and clinical characteristics associated with our research subjects are 
representative of the adult population currently seeking orthodontic treatment and are concerned 
with the issues of esthetics and duration of treatment. The results and conclusions made from our 
study have generalizability only to the efficiency and accuracy as well as discomfort associated 
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with the alignment maxillary and mandibular incisor when using accelerated (4-day) Invisalign. 
The challenges we experienced related to patient compliance wearing the aligners and using the 
vibration device reflect real-world issues common throughout all orthodontic treatment outside 
of a research setting.  
Conclusions: 
1. Accelerated (4-day) aligner wear increases efficiency but decreases accuracy of incisor 
alignment 
2. Overall treatment time using accelerated (4-day) aligner schedules may be increased due 
to need for future refinement 
3. Vibration had no effect of efficiency and accuracy of incisor alignment nor the 
discomfort associated with accelerated (4-day) Invisalign 
4. Further clinical trials with larger sample sizes are required to further determine: 
a. The ideal aligner reactivation schedule in order to maximize the efficiency and 
accuracy of clear aligner therapy in various types of malocclusions. 
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Table 1. Baseline characteristics by treatment group 
 
 
 
Table 2: Self-reported aligner use in hours per day 
 
	  	   	  	   Group	  1	   Group	  2	   Group	  3	   Total	   P-­‐value	  
T1	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   n	   7	   12	   10	   29	   	  	  
	  	   Mean	   22.6	   20.6	   23.1	   22.1	   0.89	  
	  	   SD	   1.8	   1.7	   1.4	   1.63	   	  	  
T2	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   n	   7	   12	   10	   29	   	  	  
	  	   Mean	   20.6	   20.1	   22.8	   21.167	   0.72	  
	  	   SD	   1.5	   1.3	   1.8	   1.53	   	  	  
T3	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   n	   7	   12	   10	   29	   	  	  
	  	   Mean	   20.3	   19.7	   21.7	   20.56	   0.75	  
	  	   SD	   1.8	   1.5	   1.9	   1.73	   	  	  
Tfinal	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   n	   7	   12	   10	   29	   	  	  
	  	   Mean	   20.2	   19.5	   20.8	   20.16	   0.56	  
	  	   SD	   1.7	   1.9	   2	   1.86	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Figure 1: Digital pre-treatment and post-treatment dental models (.stl files) used for 
calculating the Proximal Contact point Discrepancy Index (PCPDI). 
 
 
Figure 2: CONSORT diagram showing the flow of subjects in the study 
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Figure 3. Percentage of G3 subjects compliant with the AcceleDent Aura device in 12 weeks 
 
 
 
Figure 4. Efficiency of incisor alignment in 12 weeks 
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Figure 5. Accuracy of incisor alignment in 12 weeks 
 
 
 
Figure 6. Mean pain scores by group and time point 
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Figure 7.  Mean Analgesic Consumption by group and time point 
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THE EFFECT OF ACCELEDENT AURA ON THE ACCURACY OF OVERBITE 
CORRECTION WHEN USING ACCELERATED (4-DAY) INVISALIGN®: AN 
EXPLORTIVE RANDOMIZED CLINICAL TRIAL 
 
Introduction: 
The goal of orthodontic treatment is to produce an ideal occlusion that is morphologically 
stable, esthetic, and functional.1 However, the orthodontic market has recently experienced a 
paradigm shift towards an increased demand for consumer-driven esthetic treatment as well as a 
reduction in treatment time.2 Recent computer based surveys indicate adults and teenagers rate 
clear aligners as the most esthetic and acceptable appliance for orthodontics treatment.3 Align 
Technology (eg Invisalign®, Santa Clara, CA, USA) has met the esthetic demands of the public, 
however, orthodontic treatment time (OTT) using Invisalign® continues to be investigated.  
In addition to the traditional factors affecting duration of treatment4, OTT with clear 
aligner therapy (CAT) is further affected by: total number of aligners, rate of orthodontic tooth 
movement (OTM) programmed in each aligner, aligner reactivation schedule (ARS), and finally, 
the accuracy of treatment. The total number of aligners is determined by the severity of the initial 
malocclusion as well as the staging of OTM, which is influenced by the most complex tooth 
movement required for a single tooth, or group of teeth. The rate of OTM is determined by the 
manufacturer and reflects the maximum amount of linear (0.25mm), or angular (2 deg), 
movement a single tooth, or a small group of teeth, programmed within each aligner. 
Orthodontic providers cannot increase the default rates of OTM per aligner, but distributing the 
desired tooth movement over a larger number of aligners can reduce the rate of OTM. Reducing 
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the rate of OTM per aligner may be necessary to improve the accuracy of some complex tooth 
movement.5 
The aligner reactivation schedule (ARS) is defined as the number of days each aligner set 
is worn by the patient. ARS is critical because adequate time must be given to achieve the tooth 
movements programmed within each aligner, however, there is very little clinical evidence to 
support the most ideal regimen in terms of efficiency and accuracy of specific types of OTM. 
Historically, Align Technology, Inc. recommended 2-week ARSs as well as a daily use 
requirement of 20-22 hours, however, in October of 2016, the manufacturer deviated from the 
standard 2-week change regimen and introduced 1-week aligner wear for all Invisalign patients 
without adjunctive therapies like vibration. Align Technology, Inc. claims the recent change in 
ARS comes as a result of continued Invisalign product innovation including the “G-Series” 
features and SmartTrack® aligner material. Align Technology also states their recommendation is 
based on clinical analysis of more than 200 in-progress Invisalign cases, the experiences of 
numerous Invisalign providers, and the endorsement of the North American Clinical Advisory 
Board.6  
Despite the recommendation of Align’s Key Opinion Leaders, there is reasonable 
concern the recent announcement is in response to the ever-increasing demand for reduced 
treatment times. Factors such as: type of malocclusion, patient compliance as well as the 
experience of the treating doctor should be considered when making ARS recommendations. The 
paucity of clinical studies published by Align Technology regarding the effects of accelerated 
ARSs may indicate clinicians should proceed with caution. After all, it is the orthodontic 
provider who is liable for the results of treatment.7  
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Finally, the accuracy of CAT is a measure of how well the aligners achieve the tooth 
movements predicted by the virtual treatment plan. If the patient, or orthodontic provider is not 
satisfied with the result of treatment, he/she may decide to initiate a midcourse correction, 
refinement, or conversion to fixed appliances in order to obtain satisfactory results with 
treatment. Additional treatment following completion of the initial set of aligners increases OTT, 
which increases the burden of treatment and decreases profitability for the patients and provider, 
respectively.2 Align Technology, Inc. claims 20% to 30% of patients treated with Invisalign 
might require either midcourse correction or additional treatment with refinement aligners, 
however, many orthodontists report 70% to 80% of their Invisalign patients require midcourse 
correction, case refinement, or conversion to fixed appliances in order to obtain a satisfactory 
result with treatment.8  
Recent prospective clinical studies evaluating the efficacy of CAT using Invisalign have 
been conducted using the most current clinical protocols and aligner material. Grunheld et al9 
evaluated post-treatment models of 30 patients who had non-extraction Invisalign treatment and 
determined Invisalign is capable of achieving predicted tooth positions with high accuracy, 
however, actual outcomes differ from the predicted outcomes. Their results further indicated the 
Invisalign system under-performs with tooth movements involving maxillary lateral incisors, 
canines, first premolars as well as posterior teeth in all dimensions. Interestingly, the upper and 
lower incisors tended to be more occlusal than anticipated, which would indicate the post-
treatment overbite in patients with deep bites was larger than expected.  
As a follow-up to an initial pilot study, Krieger et al10 reported moderate to severe levels 
of lower anterior crowding can be resolved via protrusion of the anterior teeth using Invisalign. 
Achieved tooth movements were accurately predicted by the post treatment ClinCheck® models 
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with the exception of overbite, which were on average 0.71mm from predicted values. These 
results agree with data from the prospective clinical trial completed by Kravitz et al11, who 
determined extrusion (29.6%)  and intrusion (41.3%) of anterior teeth is inaccurate. Thus, there 
seems to be a trend for a high degree of discrepancy between the planned and the achieved tooth 
movements in the vertical plane. 
Some clinical studies and multiple case reports, however, have reported the Invisalign 
system is relatively successful in managing overbite correction. With outdated clinical protocols, 
Boyd and Vlaskalic12 reported correction of deep bite is one of the most predictable movements 
possible with Invisalign. Additionally, Gioncotti et al13 concluded deep bites can be effectively 
treated while using Invisalign to level the dental arches via intrusion of anterior incisors. Finally, 
a well-designed retrospective study conducted by Khosravi et al14 used cephalometric analysis on 
a large sample size to determine CAT can effectively treat deep bites as well as open bites 
patients while avoiding negative changes in those with normal overbites.  
However, the results of the studies supporting Invisalign as a means to correct deep, or 
open, bites should be interpreted with caution. When compared to fixed appliances, overbite 
correction with Invisalign in the Khosravi et al. study was only half as effective even after as 
much as three refinement treatments.14,15 Moreover, no studies have investigated the efficacy of 
overbite correction with accelerated Invisalign protocols, or in complex malocclusions such as: 
deep bites patients with spacing, or open bite patients with crowding.  
A critical review of the published clinical studies and case reports investigating the 
accuracy of the CAT indicate the capabilities of Invisalign have improved, however, we still 
have much to learn regarding the biomechanics and accuracy of the Invisalign system. In order to 
become more proficient with Invisalign, orthodontic providers must gain more understanding of 
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the inaccuracies of the ClinCheck® software as well as limitations of CAT. Expanding the 
knowledge and experience of treating various types of malocclusions will enable clinicians to 
incorporate necessary over-compensations into their virtual treatment plans.  
Increasing the rate of OTM by accelerating the complex cellular process of alveolar bone 
remodeling presents a potential way to improve the efficiency and efficacy of CAT. OrthoAccel 
Technologies, Inc. (Houston, TX) claims the application of low-frequency vibrations forces 
(30Hz) for 20 minutes per day using the AcceleDent Aura® device will result in a 50% increase 
in OTM and enable patients to utilize accelerated aligner schedules with improved efficacy.16,17  
Currently, there are very few clinical studies assessing the effect of vibration therapy on 
CAT. This is especially true for tooth movements in the vertical plane, which affect the patient’s 
overbite. A recently conducted, well-designed randomized clinical trial found no evidence of the 
AcceleDent Aura device contributing to a patients ability to complete a series of aligner with a 1-
week ARS.5 In addition to the completion rate, the study determined vibration therapy made no 
statistically significant difference in the reduction of lower incisor crowding.5 These findings do 
not support the 1-week ARS recommended by Align Technology, however, it is interesting to 
note the surprisingly high overall success rate (81%) reported in completing the series of 
aligners.  
Therefore, it seems appropriate to decrease the ARS even further and investigate the 
efficacy of 4-day change regimens with and without vibration therapy in patients with mild-
moderate malcocclusions characterized by both spacing and crowding. The purpose of our study 
is to help clinicians further understand the effects of accelerated (4-day) Invisalign® and 
vibration therapy on overbite correction and classify which patients are good candidates for 
accelerated Invisalign therapy. 
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Specific Objectives and Hypotheses 
The aim of this RCT is to determine the effect of vibration therapy and 4-day aligner 
schedule (DAS) on: (1) the accuracy of overbite correction. 
The null hypotheses tested in this study were the following: (1) vibration therapy does not 
increase the accuracy of overbite correction and (2) 4-DASs do not increase the accuracy of 
overbite correction. 
Material and Methods: 
Trial design and any changes after trial commencement 
 This study was designed as a double blinded, single-centered 3-arm, parallel, prospective 
randomized clinical trial with 1:1:1 allocation ratio.  
Participants, eligibility criteria and settings 
 Ethical approval was granted by the Office of Human Research Ethics at the University 
of North Carolina (reference number: 16-0167). The clinical trial was registered at the US 
National Institutes of Health (ClinicalTrials.gov) #NC NCT02868554. See CONSORT flow 
diagram (Figure 2). 
 The study population was drawn from patients pursuing Invisalign® treatment in the 
postgraduate orthodontic clinic of the University of North Carolina (UNC). Patients were 
included for participation based on the following criteria: (1) being within the ages of 18-65 
years old, (2) good health determined by a current medical history, (3) full adult dentition 
including second molars in both dental arches, (4) normal pulp vitality and healthy periodontal 
tissues as determined by intraoral exam, (5) initial malocclusion with mild to moderate dental 
crowding or spacing (≤ 6mm), (6) non-extraction Invisalign treatment with ClinCheck treatment 
plans prescribing more than 21 active aligners with simultaneous tooth movement of anterior 
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teeth and no deviation from default amounts of tooth movements prescribed in each aligner 
stage, (7) no mid-course correction, or additional aligners, and (8) willingness to and ability to 
comply with study procedures, attend study visits, and complete the study protocol. 
 Patients were excluded from participation based on the following criteria: (1) individuals 
diagnosed with systemic diseases such as diabetes, hypertension, temporomandibular disorders, 
or cranio-facial syndromes, (2) chronic use of any non-steroidal anti-inflammatory medications, 
estrogen, calcitonin, or corticosteroids, (3) history of use or current use of bisphosphonate 
medication or other medication fro treatment of osteoporosis, (4) current smoker (not within the 
last 6 months), (5) significant periodontal disease (>4mm pocket depth or >2mm recession), (5) 
active caries, or new dental restorations during treatment (6) initial malocclusions with severe 
crowding or spacing (>6mm), (7) impacted teeth and, or closure of extraction spaces, requiring 
fixed appliances or adjunctive procedures other than clear aligners, (8) ClinCheck treatment 
plans with less than 21 aligners, or plans that failed to start all tooth movement simultaneously, 
and finally, (9) failing to comply with research protocols.  
 Enrolled subjects were allocated into one of 3 groups: 14-DAS (control- G1), 4-DAS 
(G2), and 4-DAS plus vibration therapy using Acceledent Aura® (G3). Informed consent and 
assent were obtained prior to initiating the clinical trial protocol. In total 67 patients were 
screened for eligibility, 34 patients were excluded for not meeting the previously mentioned 
criteria, and 33 patents were enrolled under the supervision of Dr. Bill Gierie, who is an Elite top 
1% Invisalign provider and also serves as a KOL for Invisalign. Dr. Gierie was blinded to group 
allocation of all subjects during the initial set-up and approval of the ClinCheck treatment plan, 
however, he was made aware if the patient was in the study to ensure no additional modifications 
were requested to alter the rate of programmed tooth movement per aligner (0.25mm/aligner). 
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Once the aligners arrived from the manufacture, enrolled patients were scheduled for aligner 
delivery and randomly allocated to one of the 3 groups using third party randomization software.  
According to group allocation and Invisalign® start date (To), customized aligner 
schedules were issued to all subjects and recall appointments were scheduled for data 
acquisition. Subjects in the control group (G1) were instructed to wear each aligner set 14 days. 
Subjects receiving an accelerated aligner schedule (G2/G3) were instructed to wear each aligner 
set 4 days. All subjects were instructed to wear each aligner at least 22 hours per day and 
progress to the subsequent aligner based upon their customized schedule. Subjects receiving 
vibration therapy (G3) were issued a fully charged Acceledent Aura® device with operating 
instructions and compliance counseling. Vibration therapy was applied for 20 minutes per day at 
a force of .25N (25g) at a frequency of 30Hz. G3 subjects were blinded from the fact that the 
Acceledent Aura device contains Fastrac® software which is a microprocessor that stores the date 
and duration of use each time the device was activated. All subjects were recalled at the 
following time points for data collection:  T4-days, T2-weeks, T6-weeks, and T12-weeks after the 
Invisalign start date.  
The investigator completed the following research steps at each recall visit: (1) obtain 
virtual models of maxillary and mandibular dental arches using Trios 3Shape scanner and (2) 
determine discomfort experienced by the subject at the onset of subsequent aligner delivery 
using the Faces Pain Scale®. Subjects were also asked to indicate the number of hours they 
typically wear the Invisalign trays and if analgesics were used to relieve discomfort associated 
with their treatment. 
Under faculty supervision, orthodontic residents completed the following clinical steps 
specific to each recall visit: (To)[a] deliver aligner #1, (T4-days) [a] deliver aligner #s: 2-4 to 
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G2/G3 subjects only, (T2-weeks) [a] place composite attachments prescribed in the ClinCheck 
treatment plan and [b] deliver aligner #s: 2-3 to G1 subjects and aligner #s: 5-11 to G2/G3 
subjects, (T6-weeks) [a] deliver aligner #s: 4-6 to G1 subjects and aligner #s: 12-21 to G2/G3 
subjects, (T12-weeks) [a] terminate study protocol and continue treatment under the guidance of 
attending faculty, Dr. Bill Gierie. 
Outcomes (primary and secondary) and any changes after the trial commencement 
The primary outcome measure within the three groups was the percent accuracy of 
overbite (OB) correction following 12 weeks of treatment. OB was defined as the extent of 
vertical overlap, measured in mm, of the maxillary central incisors over the mandibular central 
incisors. For each subject at baseline (T0) and following 12-weeks of treatment (T12-weeks), the OB 
was determined on digital study models (.stl) captured with intra-oral scans. The percent 
accuracy of OB correction was determined by the following equation: the percent accuracy of 
OB correction 100%  [(baseline OB  – achieved OB)/(baseline OB – predicted OB)].  
Because T12 weeks in our study only reflected OB correction following the initial 12-weeks 
of treatment, the predicted OB for our subjects was determined as a percentage of the total 
predicted OB correction, which was determined by measuring the OB in the final digital models 
predicted by the ClinCheck software. For example, the equation for predicted OB in control 
group subjects (G1) was: [|initial OB|- (|initial OB - predicted OB| x |6 aligners/ total # of active 
aligners|)]. For subjects in the accelerated intervention groups (G2/G3), we used the same 
formula mentioned above but the percentage of achieved reduction in PCPDI was larger because 
the subjects completed 21 aligners rather than 6 aligners. Calculating the percent accuracy of OB 
correction helped to overcome the discrepancy between the amounts of OB correction predicted 
within each group.  Positive percentages designated favorable OB changes (bite opening for deep 
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bites and closing for open bites), while negative percentages designated unfavorable changes in 
OB (bite deepening for deep bites and opening for open bites).  
Prior to data analysis within each group, the subjects were stratified based on whether the 
predicted OB correction was simple, or complex. Subjects were determined to have simple OB 
correction if the pre-treatment malocclusion contained crowding and goal of treatment was to 
reduce the initial OB, or if the pre-treatment malocclusion contained spacing and the goal of 
treatment was to increase the initial OB. Conversely, subjects were determined to have complex 
OB correction if the pre-treatment malocclusion contained spacing and the goal of treatment was 
to decrease the initial OB, or if the pre-treatment malocclusion contained crowding and the goal 
of treatment was to increase the initial OB. (Figure 8) 
Prior to obtaining T0, T12 weeks and predicted OB measurements, we imported the stage 
final models (.stl) from the ClinCheck treatment plan as well as the scanned digital study models 
(.stl) from each time point into Geomagic DesignX64 software. For each digital model at each 
time point, a single blinded investigator (B.B) reproducibly superimposed the initial (T0) and 12-
week (T12-week) maxillary models on stable reference points on the palatal rugae.18 Subsequently, 
initial maxillary ClinCheck models were superimposed to the T0 maxillary models using a best-
fit algorithm based on reference points selected on the occlusal surfaces of the teeth. Because 
these study models represented the same model at the same time point, the best-fit algorithm 
produced a very accurate superimposition verified by mesh deviations less than 0.01mm. Once 
the initial maxillary ClinCheck and T0 models were superimposed, the final maxillary Clincheck 
model was superimposed using a transformation matrix corresponding to the newly 
superimposed initial Clincheck model. Finally, the mandibular study models for T0 and T12 weeks 
as well as the initial and final ClinCheck were oriented to their corresponding maxillary models 
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using a bite registration captured with the intra-oral scan. Superimposition of the maxillary study 
models was necessary to ensure the OB measurements were completed in the exact same 
viewpoint and the points used for OB measurement were projected in the same vertical axis. 
(Figure 9) 
Once all digital study models were superimposed in the same x-, y-, z- axis coordinate 
system, the same blinded investigator (B.B.) selected points on the incisal edges of maxillary and 
mandibular central incisors determined to represent the greatest vertical overlap. OB 
measurements were completed with calibrated digital calipers (accurate to 0.01mm) within the 
Geomagic X64 software.  
Daily compliance using the AcceleDent Aura® device as well as satisfying the use 
requirement of 20-22 hours per day for the Invisalign trays was monitored throughout the study. 
Compliance with the vibration device was measured using the OrthoAccel, Inc. proprietary 
software, FastTrac® and compliance with Invisalign was collected with a questionnaire during 
each recall appointment. 
Sample size calculation 
The main outcome measure in this study was the (1) percent accuracy of overbite (OB) 
correction during the initial 12-weeks of treatment. Sample size estimation was completed using 
G*Power 3.1 software and showed a total of 21 participants, 7 participants (7 OB measurements) 
in each treatment arm, was required to demonstrate a clinically significant difference in the 
primary outcome of a 75% increase in the accuracy of OB correction between G1 and G2/G3, 
with 80% power, a standard deviation of 0.1, and an alpha of 0.05, using two sample T-test, and 
with the null hypothesis of equal effect. In addition, to allow for a potential 30% dropout rate, the 
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sample size was increased to 30 subjects. A formal power analysis was not completed for the 
stratified OB data (simple vs complex) compared within each group.  
Interim analyses and stopping of guidelines 
 No interim analysis was performed during the study. During the design of study protocol, 
we decided the trial would be stopped if any harm came as a result of the interventions. 
Randomization 
An independent, third party biostatistician, using an electronic program, R 3.4.2, completed 
randomization of the subject allocation sequence. All subjects enrolled within the study were 
randomized in blocks of 6 to the 3 groups that correspond to one of the 3 treatment options to be 
studied. Allocation concealment was secured by contacting the sequence generator for 
assignment. 10 subjects were randomized to the 14-DAS (G1), 12 subjects were randomized to 
the 4-DAS (G2), and 11 subjects were randomized to the 4-DAS plus vibration therapy (G3). All 
subjects enrolled within the study (33) received an allocation intervention. 
Blinding 
 Blinding of either the patient, or the assigned orthodontic resident, was not possible 
during this clinical trial due to a lack of sham vibration devices. It was also the opinion of the 
investigator than a shame device was not a realistic way of eliminating the placebo effect, which 
has been repeatedly discussed in previous studies evaluating pain scores. However, the part-time 
faculty member (B.G.) was blinded during the initial set-up of the ClinCheck treatment plans and 
the research investigator (B.B.) was blinded during data analysis. The digital models used to 
perform the OB measurements were de-identified and assigned a three-digit code to ensure the 
investigator was unaware of the patient’s intervention method.  
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Statistical Analysis 
Descriptive statistics on demographic, clinical characteristics, and outcomes Invisalign 
treatment were calculated. Since a large correlation coefficient (0.25) was present between upper 
and lower teeth in the percent reduction of PCPDI, repeated measures ANOVA was used as the 
primary statistical method to account for the dependence. A categorical variable with 3 levels 
was created for the group in the linear mixed effects model with a random intercept. The 
statistical significance of the difference between groups in both primary and secondary outcomes 
was tested using a t-test obtained from the parameter estimation. Since there is no significant 
difference in baseline characteristics, we did not adjust for any covariates in the mixed effects 
model. P-values less than 0.05 were considered statistically significant. All of the statistical 
analyses were implemented using SAS 9.4 (Cary, NC). 
Compliance data downloaded from the devices were analyzed. The difference the 
primary aim between compliers and non-compliers were measured using the Wilcoxon rank sum 
test. Self-reported aligner compliance data was gathered from the subject surveys and analyzed 
with a Wilcoxon rank sum test to measure the differences between the groups. 
Results: 
Participant Flow 
Open enrollment began in May 2016 and continued until November 2017. 33 subjects 
(mean age, 32.3yrs; SD: 9.21; max: 57yrs; min: 18yrs) were randomized to one of 3 intervention 
groups: 14-day aligner schedule (G1), 4-day aligner schedule (G2), and 4-day aligner schedule + 
vibration therapy (G3). Data from 2 subjects were eliminated from the data sample prior to 
analysis because the ClinCheck® treatment plans did not initiate tooth movement simultaneously. 
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correction during the 12-week study period was less than the error of measurement (0.2mm). 
This resulted in the final analysis of 29 digital study models. The recruitment and follow-up of 
all subjects during the study is shown in the CONSORT flow diagram (Figure 2). No subject was 
lost to follow-up during this study.  
Baseline Data 
 Table 3 shows the similarity in the distributions across treatment groups for demographic, 
predicted OB correction as well as the average number of aligners used per group. Table II 
displays the mean self-reported aligner use per day within each group. Table 4 and Table 5 
indicate the differences in the desired simple and complex OB correction within each group, 
respectively. Figure 3 illustrates the compliance with the AcceleDent Aura® by subjects within 
G3. 
Numbers analyzed for the primary aim (discrepancy between predicted OB correction and 
achieved OB correction)  
 
Our results indicated the use of accelerated (4-day) aligners schedules with, our without, 
vibration tended to decrease the accuracy of OB correction. However, when analyzing the mean 
percent accuracy of OB correction (%) between all types of OB correction within each group, we 
did not find a statistically significant difference between G1 and G2/G3 (P= 0.331, 0.064) nor 
G2 and G3 (P= 0.288). Additionally, for simple and complex OB correction, mean percent 
accuracies of OB correction were not statistically different between the 3 groups (P= 0.700, .915, 
0.847). (Figure 9) Surprisingly, when comparing the percent accuracies of OB correction of 
simple OB to complex OB correction within each group, there was a significant difference 
within each group (P= 0.039, < 0.001, 0.046) (Table 10). 
Compliance was found to drop-off markedly during the period of the trial. Only 6 
participants (54%) met the criterion of being considered as good compliers by using the vibration 
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device 75% of the time or more (Figure 3). The mean percent accuracy of simple OB correction 
in compliers was 48%, while in the non-compliers the mean percent accuracy was 53%. For 
complex OB correction, the discrepancy of OB correction was -8% for compliers and -10% for 
non-compliers, thus, showing vibration therapy had little effect on the accuracy of OB 
correction. The mean compliance with aligner use was within recommended range (20.9 hours 
per day) and the means of use within the groups was not statistically different (Table 3) 
Error of the Method 
To reduce effects of random measurement error and calculate intra-operator reliability, 
the same single operator (B.B) manually repeated the steps to measure the OB 3 times and 
allowed 1-weeks time to pass between measurements. For each model at each time point, the 
accepted OB value used to calculate the percent accuracy of OB correction was the average of 3 
completed measurements. The Dahlberg19 measurement error calculations showed a 0.1mm 
difference between the initial and repeated measures. 
Harms 
 There was no evidence of adverse events, or safety hazards, to the soft or hard tissues of 
the participants during the trial.  
Discussion: 
Main findings in the context of the existing evidence, interpretation 
Undoubtedly, clear aligner therapy (CAT) has met the esthetic demands of the 
orthodontic patient and provider, but there continues to be a lack of clarity associated with 
treatment efficiency and the ability of clear aligners to achieve desired tooth movements. 
Previous clinical studies have attempted to help orthodontic providers understand the strengths 
and weaknesses of clear aligners as an orthodontic appliance, but the evidence is hardly 
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conclusive.10,11,20 It appears the efficacy of CAT is likely associated with the clinical 
characteristics of the pre-treatment malocclusion as well as the experience level of the 
orthodontic provider.11  
Orthodontic treatment time (OTT) using CAT is based on traditional biologic factors and 
clinical protocols, which are dictated by the manufacturer and orthodontic provider. 
Additionally, treatment time with CAT is based on the need for refinement aligners if the initial 
series of aligners does not produce a satisfactory result. Supporters of the AcceleDent Aura® 
therapy claim micro-vibration therapy will increase the efficacy of CAT and allow accelerated 
aligner reactivation schedules (ARS), or number of days a patient wears each aligner set.21 
However, a recently conducted RCT indicated vibration had no effect on the outcome of 
treatment when using 7-day aligner schedules.5 These results were very timely in that they give 
some evidence to support the 7-day ARS recently announced by Align Technology, Inc. for all 
Invisalign patients. 6  
In this RCT, we evaluated the effects of accelerated (4-day) CAT and vibration therapy 
on the accuracy of overbite correction. The demographics of our study sample were 64% female, 
however, this reflects a “real-world” scenario as females are generally more concerned with 
esthetics and duration of treatment.22 The average of age was similar between allocation groups 
(32.3yrs, SD: 9.85). To account for the significant difference in the predicted OB correction 
between the groups, we measured the percent accuracy of OB correction. Based on our data, 
accelerated (4-day) aligner schedules tend to exacerbate the accuracy of OB correction, however, 
we did not find a significant difference in the overall accuracy of OB correction between the 
groups. This finding likely resulted for the abnormally large standard deviations found within 
each group. 
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In an effort to explain why the standard deviations were so large in the analysis of overall 
OB correction, we stratified subjects into categories of simple and complex OB correction based 
on pre-treatment clinical characteristics (anterior spacing or crowding) and the desired effect of 
OB correction. The basis of our stratification was supported by well-established knowledge 
regarding the vertical side effects (relative intrusion or relative extrusion) associated with 
anterior space closure (lingual tipping) or anterior crowding (facial tipping), which might benefit, 
or negate, the desired OB correction. During anterior space closure with aligners, the crowns of 
the incisors tip lingually and retrocline, which causes relative extrusion and a bite deepening 
effect. With anterior crowding, the incisors expand facially and procline, which causes a relative 
intrusion and bite opening effect. Therefore, OB correction may be more accurate when the goal 
of treatment is to reduce OB with the presence of anterior dental crowding, or when the goal of 
treatment is to increase OB in the presence of anterior dental spacing (simple). Conversely, OB 
correction is less accurate when the goal of treatment is to reduce the OB in the presence of 
anterior spacing, or when the goal of treatment is to increase OB in the presence of anterior 
crowding (complex).  
Our results indicated simple OB correction is significantly more accurate that complex 
OB correction within each group. For simple OB correction, the mean percent accuracy of OB 
correction was positive, meaning there was improvement in pre-treatment OB. However, for 
complex OB correction, the percent accuracy of OB correction was negative, indicating the pre-
treatment OB worsened. Surprisingly, we did not find a significant difference in simple or 
complex OB correction between each group. This finding may indicate the most important factor 
in determining the accuracy of OB correction with aligners has less to do with the aligner 
schedule or vibration than the type of OB correction.  
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The existing literature reports mixed results regarding the accuracy of OB correction with 
aligners, however, our study is the first to specifically investigate the accuracy of OB correction 
with specific pre-treatment characteristics. Our data suggests simple OB correction is relatively 
successful with an accelerated (4-day) aligner schedule without vibration. These finding agree 
with the results of published by multiple clinical studies14,15. Conversely, our data suggests 
complex OB correction is relatively unsuccessful when using CAT and the result of treatment is 
exacerbated when using an accelerated (4-day) aligner schedule with, or without, vibration 
therapy. These findings may provide merit to the conclusions published Krieger et al23 and 
Kravitz et al8 regarding the inability to resolve deep bites when using CAT. 
Our study suggests OB correction may be a weakness of CAT, however, simple OB 
correction is more accurate than complex OB correction. Additionally, our study suggests 
accelerated (4-day) aligner schedules are not recommended when the type of OB correction 
desired is complex. The significantly reduced accuracy of complex OB correction within each 
group indicates significant compensations are indicated to obtain clinically acceptable results. In 
regards to treatment efficiency of complex OB correction, accelerated (4-day) aligner regimens 
may not reduce OTT because the increased need for compensations will increase the number of 
aligners in the series relative to a 2-week ARS. Finally, vibration therapy does not play a 
significant role in the efficacy of OB correction with CAT, thus, the additional fee associated 
with the adjunctive therapy is considered unjustified.  
No other studies have evaluated specific pretreatment clinical characteristics (such as 
anterior spacing, or crowding) with respect to accuracy of OB correction with CAT. More long-
term clinical studies evaluating the performance of accelerated aligner schedules are necessary. 
A study investigating the effect of 4-DAS and 7-DAS on the accuracy of simple and complex 
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OB correction seems appropriate. It would also be beneficial to gather information regarding the 
performance various aligner schedules with respect to specific types of tooth movements. With 
that data, provider can make a more informed decision with regard to aligner schedule based on 
pre-treatment findings instead of relying on Align’s recommendation, which may not be best for 
all patients. 
Limitations 
Clinical studies that provide good-quality patient care while testing alternative treatments 
must, by their nature, involve compromises. One limitation of our study was not blinding the 
research subjects to their intervention group. However, significant patient blinding was 
impossible while maintaining the clinical applicability of the study. Previous studies have used 
sham vibration devices, but with questionable efficacy in regards to blinding. The results of our 
study were also subject to the potential for poor patient compliance with the Invisalign, or 
vibration device. Although the recall surveys encouraged subjects to wear their aligners for 20-
22 hours per day, we were unable to verify the daily frequency of aligner use for each patient. In 
addition to the effects of compliance with the vibration devices and the Invisalign trays, our 
results were limited by a small sample size once the subjects were stratified into groups of simple 
and complex OB correction. We also did not account for the effect of posterior teeth in the OB 
measurement but according to Roozbeh et al14, most OB changes with CAT result from 
maxillary and mandibular incisor movement. Finally, we do not know the short versus long-term 
effects of vibration therapy on OTM, but the short (12-week) evaluation period in this trial may 
not have allowed for the cumulative affect of vibration therapy.  
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Generalizability 
The demographics and clinical characteristics associated with our research subjects are 
representative of the adult population currently seeking orthodontic treatment and are concerned 
with the issues of esthetics and duration of treatment. The results and conclusions made from our 
study have generalizability only to the accuracy of OB correction when using accelerated (4-day) 
Invisalign. The challenges we experienced related to patient compliance wearing the aligners and 
using the vibration device reflect real-world issues common throughout all orthodontic treatment 
outside of a research setting. 
Conclusions: 
1. Pre-treatment characteristics can be used to classify the desired OB correction using clear 
aligners  
a. Simple OB correction occurs when the goal of treatment is to reduce OB with the 
presence of anterior dental crowding, or when the goal of treatment is to increase 
OB in the presence of anterior dental spacing. 
b. Complex OB correction occurs when the goal of treatment is to reduce the OB in 
the presence of anterior dental spacing, or when the goal of treatment is to 
increase OB in the presence of anterior dental crowding.  
2. Accelerated (4-day) aligner schedules are not recommended for complex OB correction 
3. Vibration had no effect on the accuracy of OB correction 
4. OTT for patients utilizing a accelerated (4-day) aligner schedules with, or without 
vibration, may not be reduced due to an increased potential for mid-course correction 
and/or refinement 
a. All OB correction needs to be overcorrected in ClinCheck 
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i. Complex deep bite: extensive overcorrection 
1. 4-day aligner schedules may create side effects equivalent to 
closing space on a superelastic arch wire 
b. Complex open bite: stage extrusion after crowding is resolved, use IPR and 
simultaneous retraction 
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Table 3: Sample Demographics and Predicted OB Correction 
 
Table 4: Predicted Simple OB change by treatment group in 12 weeks 
 
Mean desired OB Change 
in 12 weeks (mm) 
N Mean 
change 
(mm) 
SD G1 G2 G3 
Simple        P-value     
G1 4 0.521 0.154 X     
G2 6 1.374 0.832 0.074 X   
G3 2 1.807 0.560 0.049 0.438 X 
Total 12 1.160 0.774       
 
 
Table 5: Predicted Complex OB change by treatment group 
 
Mean desired OB Change 
in 12 weeks (mm) 
   p-
value 
  
Complex N Mean 
change 
(mm) 
SD G1 G2 G3 
G1 4 0.433 0.208 X     
G2 6 1.364 0.336 <.001 X   
G3 7 0.709 0.332 0.178 0.002 X 
  17 0.875 0.435       
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Figure 8: Simple and Complex Overbite (OB) Correction 
 
Simple: relative extrusion favors desired bite deepening and relative intrusion favors desired bite 
opening 
 
 
Complex: relative extrusion negates desired bite opening and relative intrusion negates desired 
bite deepening 
 
Figure 9: Superimposition of maxillary models and Overbite (OB) measurement 
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Figure 10: Overall Accuracy of Overbite (OB) Correction in 12 weeks (%) 
 
 
 
Figure 11: Accuracy of Simple vs Complex Overbite Correction in 12 weeks (%) 
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